Tumour Shrinkage and Contour Change during Radiotherapy Increase the Dose to Organs at Risk but not the Target Volumes for Head and Neck Cancer Patients Treated on the TomoTherapy HiArt™ System

Clinical Oncology

Volumn 23, Issue 1, 2011, Pages 40-47

  Loo, H ^a   Fairfoul, J ^a   Chakrabarti, A ^a   Dean, J C ^a   Benson, R J ^a   Jefferies, S J ^a   Burnet, N G ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Head and neck cancer; Intensity modulated radiotherapy; Tomotherapy

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEVICE; GEOMETRY; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PAROTID GLAND; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TOMOTHERAPY; TREATMENT PLANNING; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; ORGANS AT RISK; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 78650419961     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.09.003     Document Type: Article

References (33)

1. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001, 51(4):880-914. Intensity Modulated Radiation Therapy Collaborative Working Group.
2. Pow E.H., Kwong D.L., McMillan A.S., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006, 66(4):981-991.
3. Xing L., Thorndyke B., Schreibmann E., et al. Overview of image-guided radiation therapy. Med Dosim 2006, 31(2):91-112.
4. Verellen D., Ridder M.D., Linthout N., Tournel K., Soete G., Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer 2007, 7(12):949-960.
5. Donovan E., Bleakley N., Denholm E., et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007, 82(3):254-264. Breast Technology Group.
6. Veldeman L., Madani I., Hulstaert F., De Meerleer G., Mareel M., De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 2008, 9(4):367-375.
7. Nutting C., A'Hern R., Rogers M.S., et al. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). J Clin Oncol 2009, 27:18s. on behalf of the PARSPORT Trial Management Group, (suppl; abstr LBA6006).
8. Lee N., Puri D.R., Blanco A.I., et al. Intensity-modulated radiation therapy for head and neck cancers: an update. Head Neck 2007, 29:387-400.
9. Gregoire V., De Neve W., Eisbruch A., et al. Intensity-modulated radiation therapy for head and neck carcinoma. Oncologists 2007, 12:555-564.
10. Eisbruch A. Intensity modulated radiation therapy in the treatment of head and neck cancer. Nat Clin Pract Oncol 2005, 2:34-39.
11. Bjordal K., Kaasa S., Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 1994, 28:847-856.
12. Roesink J.M., Moerland M.A., Battermann J.J., et al. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in head and neck region. Int J Radiat Oncol Biol Phys 2001, 51:938-946.
13. Eisbruch A., Ten Haken R.K., Kim H.M., et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999, 45:577-587.
14. Eisbruch A., Ship J.A., Dawson L.A., et al. Salivary gland sparing and improved target irradiation by conformal and intensity-modulated irradiation of head and neck cancer. World J Surg 2003, 27:832-837.
15. Hansen E.K., Bucci M.K., Quivey J.M., et al. Repeat CT imaging and replanning during IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006, 64:355-362.
16. Barker J.L., Garden A.S., Ang K.K., et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy of head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004, 59:960-970.
17. Ballivy O., Parker W., Vuong T., et al. Impact of geometric uncertainties on the dose distribution during intensity-modulated radiotherapy (IMRT) of head and neck cancer: the need for planning target volume (PTV) and planning organ at risk volume (PRV). Curr Oncol 2006, 13:108-115.
18. Wu Q., Chi Y.W., Chen P.Y., et al. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys 2009, 75:924-932.
19. Burnet N.G., Adams E.J., Fairfoul J., et al. Practical aspects of implementation of helical tomotherapy for intensity-modulated and image-guided radiotherapy. Clin Oncol 2010, 22(4):294-312.
20. Daisne J.F., Duprez T., Weynand T., et al. Tumour volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004, 233:93-100. Erratum in: Radiology 2005;235(3):1086.
21. Ahmed M., Hansen V.N., Harrington K.J., Nutting C.M. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma. Med Dosim 2009, 34(3):217-224.
22. Bauman G., Yartsev S., Rodrigues G., et al. A prospective evaluation of helical tomotherapy. Int J Radiat Oncol Biol Phys 2007, 68(2):632-641.
23. Fiorino C., Dell'Oca I., Pierelli A., et al. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol 2006, 78(3):276-282.
24. Sterzing F., Schubert K., Sroka-Perez G., Kalz J., Debus J., Herfarth K. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol 2008, 184(1):8-14.
25. Galvin J.M., Ezzell G., Eisbrauch A., et al. Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 2004, 58(5):1616-1634. American Society for Therapeutic Radiology and Oncology, American Association of Physicists in MedicineAmerican Association of Physicists in Medicine.
26. Barnett G.C., Wilkinson J., Moody A.M., et al. A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. Radiother Oncol 2009, 92(1):34-41.
27. Chao K.S., Majhail N., Huang C.J., et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 2001, 61(3):275-280.
28. Duthoy W., Boterberg T., Claus F., et al. Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients. Cancer 2005, 104(1):71-82.
29. Cozzarini C., Fiorino C., Di Muzio N., et al. Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer. Radiother Oncol 2007, 84(2):164-170.
30. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70(4):1124-1129.
31. Mundt A.J., Mell L.K., Roeske J.C. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003, 56(5):1354-1360.
32. Vásquez Osorio E.M., Hoogeman M.S., Al-Mamgani A., et al. Local anatomical changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correction with dose, studied in detail with non-rigid registration. Int J Radiat Oncol Biol Phys 2008, 70:875-882.
33. Robar J.L., Day A., Clancey J., et al. Spatial and dosimetric variability of organs at risk in head and neck intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2007, 69:1121-1130.